单位：人民币元
                                    本报告期末          上年度期末
总资产                        3,487,048,255.84    2,844,554,643.49
所有者权益(或股东权益)        1,248,127,990.09      869,091,415.75
每股净资产                                2.77                1.93
                                 报告期(1-6月)            上年同期
营业总收入                    2,039,819,198.49    1,010,347,751.28
净利润                          417,072,886.64        3,706,006.61
扣除非经常性损益后的净利润      410,348,785.49        3,558,040.30
基本每股收益                             0.927               0.008
扣除非经常性损益后的基本每股收益         0.912               0.008
净资产收益率(%)                          33.42               0.475
每股经营活动产生的现金流量净额            0.57                0.08
→查看浙江医药详细信息